OncoCyte (OCX)
(Delayed Data from NSDQ)
$3.05 USD
+0.06 (2.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $3.19 +0.14 (4.59%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 29% (178 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.40 | 2.03 | 9.99 |
Current Quarter Estimate | NA | 5.16 | 63.00 |
Year Ago Quarter Estimate | -0.57 | 1.42 | 52.25 |
Next Quarter Estimate | NA | 4.73 | 66.00 |
Next Year Estimate | NA | 25.99 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 7.30 | 15.70 |
Next Year | NA | 18.10 | 11.30 |
Last 5 Years | NA | 9.60 | 8.10 |
Next 5 Years | NA | 13.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.71 |
Price/Book (MRQ) | 1.80 | 2.06 |
Price/Cash Flow (MRFY) | NA | 13.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -3,558.46% | -12.48% |
Return on Equity (TTM) | -149.88% | -14.67% |
Debt to Equity (MRQ) | NA | 27.45 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.